Helicobacter pylori eradication prevents extension of intestinalization even in the high-risk group for gastric cancer

Digestion

Volumn 81, Issue 4, 2010, Pages 223-230

  Shiotani, Akiko ^a   Nishi, Ryuji ^a   Uedo, Noriya ^b   Iishi, Hiroyasu ^b   Tsutsui, Hideaki ^a   Ishii, Manabu ^a   Imamura, Hiroshi ^a   Kamada, Tomoari ^a   Hata, Jiro ^a   Haruma, Ken ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Atrophic gastritis; CDX2; Gastric cancer; Helicobacter pylori eradication

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; MESSENGER RNA; MUCIN 2; OMEPRAZOLE; RABEPRAZOLE; TRANSCRIPTION FACTOR CDX2;

AGED; ARTICLE; CANCER RISK; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPIC SURGERY; ERADICATION THERAPY; FEMALE; GENE EXPRESSION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; MALE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER;

AGED; ANTI-BACTERIAL AGENTS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROBABILITY; PROTON PUMP INHIBITORS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; TRANS-ACTIVATORS; TREATMENT OUTCOME;

EID: 75149124795     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000264651     Document Type: Article

References (34)

1. Graham DY, Shiotani A: The time to eradicate gastric cancer is now. Gut 2005; 54: 735-738. (Pubitemid 40732080)
2. Sipponen P, Kimura K: Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time. Eur J Gastroenterol Hepatol 1994; 6(suppl 1):S79-S83.
3. Correa P: Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740. (Pubitemid 23006271)
4. Gendler SJ, Spicer AP: Epithelial mucin genes. Annu Rev Physiol 1995; 57: 607-634.
5. Williams SJ, McGuckin MA, Gotley DC, Eyre HJ, Sutherland GR, Antalis TM: Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 1999; 59: 4083-4089.
6. Lapensee L, Paquette Y, Bleau G: Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9). Fertil Steril 1997; 68: 702-708. (Pubitemid 27454333)
7. Shankar V, Pichan P, Eddy RL Jr, Tonk V, Nowak N, Sait SN, Shows TB, Schultz RE, Gotway G, Elkins RC, Gilmore MS, Sachdev GP: Chromosomal localization of a human mucin gene (MUC8) and cloning of the CDNA corresponding to the carboxy terminus. Am J Respir Cell Mol Biol 1997; 16: 232-241. (Pubitemid 127497445)
8. Macdonald PM, Struhl G: A molecular gradient in early drosophila embryos and its role in specifying the body pattern. Nature 1986; 324: 537-545. (Pubitemid 17185068)
9. Moreno E, Morata G: Caudal is the Hox gene that specifies the most posterior Drosophile segment. Nature 1999; 400: 873-877. (Pubitemid 29406723)
10. Silberg DG, Swain GP, Suh ER, Traber PG: Cdx1 and Cdx2 expression during intestinal development. Gastroenterology 2000; 119: 961-971.
11. Mutoh H, Sakurai S, Satoh K, Tamada K, Kita H, Osawa H, Tomiyama T, Sato Y, Yamamoto H, Isoda N, Yoshida T, Ido K, Sugano K: Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res 2004; 64: 7740-7747. (Pubitemid 39446905)
12. Beck F, Chawengsaksophak K, Waring P, Playford RJ, Furness JB: Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc Natl Acad Sci USA 1999; 96: 7318-7323. (Pubitemid 29299659)
13. Phillips RW, Frierson HF Jr, Moskaluk CA: Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol 2003; 27: 1442-1447. (Pubitemid 37315196)
14. Silberg DG, Sullivan J, Kang E, Swain GP, Moffett J, Sund NJ, Sackett SD, Kaestner KH: Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 2002; 122: 689-696. (Pubitemid 34173821)
15. Matsumoto K, Mizoshita T, Tsukamoto T, Ogasawara N, Hirata A, Shimizu Y, Haneda M, Yamao K, Tatematsu M: Cdx2 expression in pancreatic tumors: relationship with prognosis of invasive ductal carcinomas. Oncol Rep 2004; 12: 1239-1243.
16. Piscitelli D, Ingravallo G, Resta L, Fiore MG, Maiorano E: Oncocytic adenocarcinoma of the rectum with diffuse intraluminal microcalcifications: the first reported case. Virchows Arch 2003; 443: 579-582. (Pubitemid 37363387)
17. Kaimaktchiev V, Terracciano L, Tornillo L, Spichtin H, Stoios D, Bundi M, Korcheva V, Mirlacher M, Loda M, Sauter G, Corless CL: The homeobox intestinal differentiation factor Cdx2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol 2004; 17: 1392-1399. (Pubitemid 39472995)
18. Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y, Tatematsu M: Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol 2003; 129: 727-734. (Pubitemid 38002304)
19. Seno H, Oshima M, Taniguchi MA, Usami K, Ishikawa TO, Chiba T, Taketo MM: Cdx2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: prognostic implications. Int J Oncol 2002; 21: 769-774.
20. Shiotani A, Uedo N, Iishi H, Tatsuta M, Ishiguro S, Nakae Y, Kamada T, Haruma K, Merchant JL: Re-expression of sonic hedgehog and reduction of Cdx2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia. Int J Cancer 2007; 121: 1182-1189. (Pubitemid 47293783)
21. Shiotani A, Kamada T, Yamanaka Y, Manabe N, Kusunoki H, Hata J, Haruma K: Sonic hedgehog and cdx2 expression in the stomach. J Gastroenterol Hepatol 2008; 23(suppl 2):S161-S166.
22. Shiotani A, Iishi H, Uedo N, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Merchant JL: Evidence that loss of sonic hedgehog is an indicator of Helicobater pylori -induced atrophic gastritis progressing to gastric cancer. Am J Gastroenterol 2005; 100: 581-587. (Pubitemid 40487556)
23. Ravizza M: Does Helicobacter pylori eradication modify intestinal metaplasia evolution in the stomach? Minerva Gastroenterol Dietol 2002; 48: 165-167.
24. Satoh K, Mutoh H, Eda A, Yanaka I, Osawa H, Honda S, Kawata H, Kihira K, Sugano K: Aberrant expression of Cdx2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori . Helicobacter 2002; 7: 192-198. (Pubitemid 34665837)
25. Tsukamoto T, Inada K, Tanaka H, Mizoshita T, Mihara M, Ushijima T, Yamamura Y, Nakamura S, Tatematsu M: Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinalmixed to complete intestinal metaplasia. J Cancer Res Clin Oncol 2004; 130: 135-145. (Pubitemid 38392346)
26. Vauhkonen M, Vauhkonen H, Sipponen P: Helicobacter pylori infection induces a reversible expression of the Cdx2 transcription factor protein in human gastric epithelium. Scand J Gastroenterol 2008; 43: 915-921.
27. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of china: a randomized controlled trial. JAMA 2004; 291: 187-194. (Pubitemid 38082812)
28. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M: Effect of eradication of helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an openlabel, randomised controlled trial. Lancet 2008; 372: 392-397.
29. Yasunaga Y, Shinomura Y, Kanayama S, Yabu M, Nakanishi T, Miyazaki Y, Murayama Y, Bonilla-Palacios JJ, Matsuzawa Y: Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori -associated enlarged fold gastritis. Gut 1994; 35: 1571-1574. (Pubitemid 24980360)
30. Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY: Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1997; 32: 664-668. (Pubitemid 27334475)
31. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE: Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 15-24. (Pubitemid 27281753)
32. Ruiz B, Correa P, Fontham ET, Ramakrishnan T: Antral atrophy, Helicobacter pylori colonization, and gastric pH. Am J Clin Pathol 1996; 105: 96-101. (Pubitemid 26024773)
33. Shiotani A, Haruma K, Uedo N, Iishi H, Ishihara R, Tatsuta M, Kumamoto M, Nakae Y, Ishiguro S, Graham DY: Histological risk markers for non-cardia early gastric cancer. Pattern of mucin expression and gastric cancer. Virchows Arch 2006; 449: 652-659. (Pubitemid 44832636)
34. Shiotani A, Iishi H, Uedo N, Ishihara R, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Hinoi T, Merchant JL: Helicobacter pylori -induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression. Aliment Pharmacol Ther 2006; 24(suppl 4):71-80. (Pubitemid 46058838)